First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).

@article{Levy2009FirstFA,
  title={First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke).},
  author={Elad I. Levy and Adnan H. Siddiqui and Annemarie Crumlish and Kenneth V. Snyder and Erik Friedrich Hauck and David J. Fiorella and L N Hopkins and J D Mocco},
  journal={Stroke},
  year={2009},
  volume={40 11},
  pages={
          3552-6
        }
}
BACKGROUND AND PURPOSE Acute revascularization is associated with improved outcomes in ischemic stroke patients. However, it is unclear which method of intraarterial intervention, if any, is ideal. Numerous case series and cardiac literature parallels suggest that acute stenting may yield high revascularization levels with low associated morbidity. We therefore conducted a Food and Drug Administration-approved prospective pilot trial to evaluate the safety of intracranial stenting for acute… CONTINUE READING
Highly Cited
This paper has 126 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 70 extracted citations

Causes and Solutions of Endovascular Treatment Failure

Journal of stroke • 2017
View 15 Excerpts
Highly Influenced

Endovascular treatment for AIS with underlying ICAD.

Journal of neurointerventional surgery • 2017

126 Citations

0102030'11'13'15'17'19
Citations per Year
Semantic Scholar estimates that this publication has 126 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
Showing 1-10 of 37 references

treatment

EI Levy, R Mehta, +8 authors LN Hopkins
2009

( IMS ) II Study

MK Hong, SW Park, JJ Kim, CW Lee, SJ Park
2007